Tocilizumab in Coronavirus Disease 2019: Give It Time!

Quentin Richier^{1

2}, Léo Plaçais^{3

4}, Karine Lacombe^{1

4}, Olivier Hermine^{2

3

5}

Affiliations

¹ Department of Infectious Diseases, Saint Antoine Hospital, Assistance Publique des Hôpitaux de Paris, Paris, France.
² University of Paris, Paris, France.
³ Department of Hematology, Necker Hospital, Assistance Publique des Hôpitaux de Paris, Paris, France.
⁴ Sorbonne University, Paris, France.
⁵ Imagine Institute, Inserm U1163, Paris, France.

Editorial

Quentin Richier et al. Clin Infect Dis. 2021.

. 2021 Dec 16;73(12):2368-2369.

doi: 10.1093/cid/ciab081.

Quentin Richier^{1

2}, Léo Plaçais^{3

4}, Karine Lacombe^{1

4}, Olivier Hermine^{2

3

5}

¹ Department of Infectious Diseases, Saint Antoine Hospital, Assistance Publique des Hôpitaux de Paris, Paris, France.
² University of Paris, Paris, France.
³ Department of Hematology, Necker Hospital, Assistance Publique des Hôpitaux de Paris, Paris, France.
⁴ Sorbonne University, Paris, France.
⁵ Imagine Institute, Inserm U1163, Paris, France.

No abstract available

Comment in

Reply to Richier et al.
Malgie J, Schoones JW, Pijls BG. Malgie J, et al. Clin Infect Dis. 2021 Dec 16;73(12):2369. doi: 10.1093/cid/ciab082. Clin Infect Dis. 2021. PMID: 33515251 No abstract available.

Decreased Mortality in Coronavirus Disease 2019 Patients Treated With Tocilizumab: A Rapid Systematic Review and Meta-analysis of Observational Studies.
Malgie J, Schoones JW, Pijls BG. Malgie J, et al. Clin Infect Dis. 2021 Jun 1;72(11):e742-e749. doi: 10.1093/cid/ciaa1445. Clin Infect Dis. 2021. PMID: 32964913 Free PMC article.